Octagos Health Revolutionizes Cardiac Care with $43M Funding Boost
July 13, 2024, 9:35 pm
Octagos Health,
Total raised: $43M
Octagos Health, a trailblazer in AI-driven cardiac device monitoring, secures a massive $43M in Series B funding. Led by Morgan Stanley Expansion Capital, this investment propels Octagos Health towards its mission of transforming cardiac care through cutting-edge technology and comprehensive patient monitoring.
Octagos Health's AI platform, Atlas AI, is a game-changer in the healthcare industry. With its high accuracy and sensitivity in detecting critical cardiac events, Atlas AI automates physician workflows, allowing for personalized patient care and informed decision-making. This innovative technology empowers healthcare providers to improve patient outcomes and streamline clinic operations.
The company's comprehensive platform offers seamless integration with existing electronic health records, ensuring data accessibility for enhanced care coordination. Customizable reporting features enable healthcare providers to tailor reports for optimal clinical decision-making, making Octagos Health a vital tool for modern cardiology practices.
CEO Dr. Shanti Bansal envisions a future where Octagos Health's AI-based clinical decision support engine revolutionizes healthcare. With the support of lead investor Morgan Stanley Expansion Capital and continued backing from Mucker Capital, Octagos Health is poised for rapid growth and expansion into new areas of cardiac care.
From humble beginnings servicing a single cardiology clinic to becoming one of the largest cardiac remote monitoring companies in the US, Octagos Health is on a mission to revolutionize cardiac care through technology, innovation, and a commitment to improving patient outcomes. With this latest funding boost, Octagos Health is well-positioned to lead the charge in AI-driven cardiac care and shape the future of healthcare.
Octagos Health's AI platform, Atlas AI, is a game-changer in the healthcare industry. With its high accuracy and sensitivity in detecting critical cardiac events, Atlas AI automates physician workflows, allowing for personalized patient care and informed decision-making. This innovative technology empowers healthcare providers to improve patient outcomes and streamline clinic operations.
The company's comprehensive platform offers seamless integration with existing electronic health records, ensuring data accessibility for enhanced care coordination. Customizable reporting features enable healthcare providers to tailor reports for optimal clinical decision-making, making Octagos Health a vital tool for modern cardiology practices.
CEO Dr. Shanti Bansal envisions a future where Octagos Health's AI-based clinical decision support engine revolutionizes healthcare. With the support of lead investor Morgan Stanley Expansion Capital and continued backing from Mucker Capital, Octagos Health is poised for rapid growth and expansion into new areas of cardiac care.
From humble beginnings servicing a single cardiology clinic to becoming one of the largest cardiac remote monitoring companies in the US, Octagos Health is on a mission to revolutionize cardiac care through technology, innovation, and a commitment to improving patient outcomes. With this latest funding boost, Octagos Health is well-positioned to lead the charge in AI-driven cardiac care and shape the future of healthcare.